• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.67% Nasdaq Up1.47%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    28.47 Up 0.60(2.15%) May 27, 4:00PM EDT
    |After Hours : 28.60 Up 0.13 (0.46%) May 27, 4:36PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 486   1,477   1,101   592  
    Cost of Revenue -   -   -   -  
    Gross Profit 486   1,477   1,101   592  
    Operating Expenses
    Research Development25,125  27,026  26,186  24,099  
    Selling General and Administrative6,089  6,249  5,004  4,787  
    Non Recurring -   -   -   -  
    Others253  253  253  254  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (30,981) (32,051) (30,342) (28,548)
    Income from Continuing Operations
    Total Other Income/Expenses Net807  229  2,261  274  
    Earnings Before Interest And Taxes(30,174)(31,822)(28,081)(28,274)
    Interest Expense -   -   -   -  
    Income Before Tax(30,174)(31,822)(28,081)(28,274)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(30,174)(31,822)(28,081)(28,274)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (30,174) (31,822) (28,081) (28,274)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (30,174) (31,822) (28,081) (28,274)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.